{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:49:23Z","timestamp":1770839363390,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jiac.2022.08.011","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T23:29:19Z","timestamp":1661297359000},"page":"1667-1671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ceftazidime encephalopathy developed without the elevation of cerebrospinal fluid concentration of ceftazidime: A case report of two cases"],"prefix":"10.1016","volume":"28","author":[{"given":"Masataro","family":"Toda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8246-8675","authenticated-orcid":false,"given":"Ayumi","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-1684","authenticated-orcid":false,"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munekazu","family":"Ryuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.08.011_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jns.2019.01.018","article-title":"Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database","volume":"398","author":"Lacroix","year":"2019","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.jiac.2022.08.011_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/0259-1162.159773","article-title":"Convulsions following rapid ceftazidime administration for preinduction antibiotic prophylaxis during neurosurgical procedure","volume":"9","author":"Haldar","year":"2015","journal-title":"Anesth Essays Res"},{"key":"10.1016\/j.jiac.2022.08.011_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8936478","article-title":"Jerky movement with ceftazidime: a case of ceftazidime-induced neurotoxicity with a review of the literature","volume":"2019","author":"Al-Sadawi","year":"2019","journal-title":"Case Rep Med"},{"issue":"12","key":"10.1016\/j.jiac.2022.08.011_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40264-017-0578-2","article-title":"Neurological adverse effects attributable to beta-lactam antibiotics: a literature review","volume":"40","author":"Deshayes","year":"2017","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.jiac.2022.08.011_bib5","article-title":"Myoclonus from antibiotic therapy (Ceftazidime-induced neurotoxicity): a case report and review","volume":"10","author":"Ong","year":"2018","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jiac.2022.08.011_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/AAC.40.3.763","article-title":"Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies","volume":"40","author":"Nau","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2022.08.011_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.24.1.126","article-title":"Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis","volume":"24","author":"Modai","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2022.08.011_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.26.1.115","article-title":"Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation","volume":"26","author":"Fong","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2022.08.011_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.23.3.369.32100","article-title":"Retrospective review of neurotoxicity induced by cefepime and ceftazidime","volume":"23","author":"Chow","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.jiac.2022.08.011_bib10","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/WNL.41.12.2008","article-title":"Truncal asterixis associated with ceftazidime, a third-generation cephalosporin","volume":"41","author":"Hillsley","year":"1991","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jiac.2022.08.011_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)00767-7","article-title":"Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure","volume":"111","author":"Martinez-Rodriguez","year":"2001","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.jiac.2022.08.011_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0897190015608503","article-title":"Probable nonconvulsive status epilepticus with the use of high-dose continuous infusion ceftazidime","volume":"29","author":"Collins","year":"2016","journal-title":"J Pharm Pract"},{"issue":"4","key":"10.1016\/j.jiac.2022.08.011_bib13","first-page":"289","article-title":"Ceftazidime in the therapy of pseudomonal meningitis","volume":"4","author":"Marone","year":"1985","journal-title":"Chemioterapia"},{"issue":"Suppl A","key":"10.1016\/j.jiac.2022.08.011_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/12.suppl_A.275","article-title":"Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid","volume":"12","author":"Walstad","year":"1983","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jiac.2022.08.011_bib15","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1128\/AAC.44.11.3217-3219.2000","article-title":"Effect of ceftazidime on systemic cytokine concentrations in rats","volume":"44","author":"Alkharfy","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jiac.2022.08.011_bib16","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00134-004-2285-6","article-title":"Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy","volume":"30","author":"Eggers","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2022.08.011_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104371","article-title":"Kynurenine metabolism and inflammation-induced depressed mood: a human experimental study","volume":"109","author":"Kruse","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.jiac.2022.08.011_bib18","doi-asserted-by":"crossref","first-page":"F565","DOI":"10.1152\/ajprenal.2000.279.3.F565","article-title":"Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency","volume":"279","author":"Saito","year":"2000","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"10.1016\/j.jiac.2022.08.011_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/WNL.42.1.43","article-title":"Neuroactive kynurenines in Lyme borreliosis","volume":"42","author":"Halperin","year":"1992","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jiac.2022.08.011_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ana.410260215","article-title":"Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome","volume":"26","author":"Heyes","year":"1989","journal-title":"Ann Neurol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22002379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22002379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:54Z","timestamp":1761159894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22002379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1341321X22002379"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.08.011","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftazidime encephalopathy developed without the elevation of cerebrospinal fluid concentration of ceftazidime: A case report of two cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}